India approves Novo Nordisk's obesity drug Wegovy for fatty liver disease - Reuters
India approves Novo Nordisk's obesity drug Wegovy for fatty liver disease Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxOX1FncDFzSWFMZDR6aHBSZHRNd3hDX3BHRnVsNkF6V01Ud1BwWWhSMU9TREFneEFZd2Z6dlI1OUpEMkF1cmVLWjBvVS1lWkd2LU5aWVdSWFpUdkdOSlk4WW5IRm05ajBLUzlBdm9iWDZ6bjBLWWw0SHdCTTE2TU9GaXhrN0E4d1ZNRlNkVXNEV2NoMUttVzdhLS1EQlFDMXJackIwYm9FQ2V6c211RmwxT0NXTTJOS19GNXdPUmZzaWhTb0ZkbWx5MzBxRWx0VUp1blBBWjhRaw?oc=5" target="_blank">India approves Novo Nordisk's obesity drug Wegovy for fatty liver disease</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters
October 7, 2026 at 07:39 AMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMNew global guidelines warn against obesity drugs for children under 10
Care should focus on healthy eating and exercise, not medicines such as weight-loss injections, says the World Health Organization
October 7, 2026 at 08:07 AMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMUS FDA flags four deaths in Newron's schizophrenia drug studies - Reuters
US FDA flags four deaths in Newron's schizophrenia drug studies Reuters
October 8, 2026 at 05:47 PM